DH240719C17500
- 0.05
- 0.000.00%
Definitive Healthcare Newsroom
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report
Baker Tilly and Definitive Healthcare Enhance Life Sciences Compliance
Leading advisory, tax and assurance firm Baker Tilly announces its collaboration with Definitive Healthcare to streamline fair market value (FMV) and key opinion leader (KOL) compliance procedures for life sciences
Definitive Healthcare Launches Redesigned Mobile App to Enhance Access to Healthcare Commercial Intelligence
FRAMINGHAM, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a leader in healthcare commercial intelligence, today announced the launch of a redesigned mobile app for its popular View Suite
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of Directors (the
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
FRAMINGHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced it has been named the 2024 Databricks Healthcare and
Definitive Healthcare Corp. (NASDAQ:DH) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
To the annoyance of some shareholders, Definitive Healthcare Corp. (NASDAQ:DH) shares are down a considerable 25% in the last month, which continues a horrid run for the company.
Definitive Healthcare Publishes 2023 Sustainability Report
Second annual report showcases Definitive Healthcare's continued successes related to culture, governance, and the environmentFRAMINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Definitive Healthca
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim
Express News | Definitive Healthcare Corp: Jason Krantz Will Continue to Serve on Board of Directors as Executive Chairman After CEO Transition.
Express News | Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
Press Release: Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise FRAMINGHAM, Mass., May 28, 2024 (G
Express News | Definitive Healthcare Corp - on May 20 Appointed Kevin Coop to Position of Chief Executive Officer
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that
Express News | Definitive Healthcare Corp : Jefferies Cuts Target Price to $10 From $12
Definitive Healthcare Corp. (NASDAQ:DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating
Definitive Healthcare (DH) has an average rating of outperform and price targets ranging from $7 to $12, according to analysts polled by Capital IQ.
Express News | Definitive Healthcare Corp : Barclays Cuts Target Price to $7 From $11